AR004224A1 - Procedimiento para la inactivacion de virus en soluciones de proteinas - Google Patents

Procedimiento para la inactivacion de virus en soluciones de proteinas

Info

Publication number
AR004224A1
AR004224A1 ARP960104859A ARP960104859A AR004224A1 AR 004224 A1 AR004224 A1 AR 004224A1 AR P960104859 A ARP960104859 A AR P960104859A AR P960104859 A ARP960104859 A AR P960104859A AR 004224 A1 AR004224 A1 AR 004224A1
Authority
AR
Argentina
Prior art keywords
procedure
viruses
inactivation
protein solutions
incubation
Prior art date
Application number
ARP960104859A
Other languages
English (en)
Original Assignee
Grifols Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grifols Sa filed Critical Grifols Sa
Publication of AR004224A1 publication Critical patent/AR004224A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se describe un procedimiento industrial para inactivar virus en general (con y sin cubierta lipídica) de forma eficiente, en medios que contienenproteínas para uso terapéutico, sin que se produzca desnaturalización ni pérdida relevante deactividad biológica, mediante incubación a pH extremo(álcali) en un medio estabilizado.
ARP960104859A 1995-11-03 1996-10-23 Procedimiento para la inactivacion de virus en soluciones de proteinas AR004224A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09502143A ES2099678B1 (es) 1995-11-03 1995-11-03 Procedimiento para la inactivacion de virus en proteinas.

Publications (1)

Publication Number Publication Date
AR004224A1 true AR004224A1 (es) 1998-11-04

Family

ID=8292048

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960104859A AR004224A1 (es) 1995-11-03 1996-10-23 Procedimiento para la inactivacion de virus en soluciones de proteinas

Country Status (12)

Country Link
US (1) US5932468A (es)
EP (1) EP0771567B1 (es)
JP (1) JP3024073B2 (es)
AR (1) AR004224A1 (es)
AT (1) ATE211928T1 (es)
CZ (1) CZ292651B6 (es)
DE (1) DE69618536T2 (es)
ES (2) ES2099678B1 (es)
HU (1) HU221239B1 (es)
MX (1) MX9605278A (es)
SK (1) SK281404B6 (es)
UY (1) UY24358A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9900428D0 (en) * 1999-01-08 1999-02-24 Nat Blood Authority Virus inactivation process
PT1820516E (pt) 1999-02-22 2013-10-31 Baxter Int Novas formulações de factor viii isentas de albumina
US20090017069A1 (en) 2000-06-29 2009-01-15 Lipid Sciences, Inc. SARS Vaccine Compositions and Methods of Making and Using Them
CN100457896C (zh) * 2005-10-26 2009-02-04 李法卿 灭活生物制品中病毒和去除细菌内毒素的方法
BRPI0921429B1 (pt) 2008-11-07 2022-07-12 Takeda Pharmaceutical Company Limited Formulação farmacêutica liofilizada estável, e, método para preparar um fator liofilizado estável
DK3436593T3 (da) * 2016-03-28 2023-02-20 Ultragenyx Pharmaceutical Inc Fremgangsmåder til varmeinaktivering af adenovirus
KR101938304B1 (ko) 2016-05-13 2019-04-10 연세대학교 산학협력단 비대칭형 커프 구조를 갖는 구강 또는 비강 기관 삽관 튜브
WO2018119561A1 (zh) * 2016-12-26 2018-07-05 通博国际有限公司 可塌陷鼻腔喷射导管

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941696A (en) * 1973-12-20 1976-03-02 Baylor College Of Medicine Sterilization of holding tanks and toilet bowls by quaternary compounds
US4055655A (en) * 1975-07-21 1977-10-25 National Research Laboratories Complexes of heavy metal ions and polyfunctional organic ligands used as antimicrobial agents
JPS53142593A (en) * 1977-12-12 1978-12-12 Green Cross Corp:The Stabilization of urokinase by heating
JPH0669961B2 (ja) * 1984-09-25 1994-09-07 株式会社ミドリ十字 免疫グロブリンの加熱処理方法
JPH07121877B2 (ja) * 1986-05-31 1995-12-25 株式会社ミドリ十字 静注用非化学修飾免疫グロブリンの加熱処理方法
DE3816139A1 (de) * 1987-10-17 1989-04-27 Bayer Ag Verfahren zur herstellung von paramunitaetsinducern
ATE85220T1 (de) * 1988-05-27 1993-02-15 Centre Regional De Transfusion Verfahren zur herstellung eines hochreinen, virusfreien antihaemophiliefaktors mittels chromatographie.
FR2695140B1 (fr) * 1992-08-06 1994-11-04 Aetsrn Procédé d'inactivation virale des produits plasmatiques par des fluides supercritiques ou subcritiques.
GB9306806D0 (en) * 1993-04-01 1993-05-26 Unilever Plc Disinfectant compositions
SE9301582D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Purification of plasma proteins

Also Published As

Publication number Publication date
DE69618536T2 (de) 2002-09-12
CZ321596A3 (en) 1997-05-14
ES2099678B1 (es) 1998-02-16
DE69618536D1 (de) 2002-02-21
EP0771567A1 (en) 1997-05-07
HU221239B1 (en) 2002-08-28
SK140796A3 (en) 1997-07-09
MX9605278A (es) 1997-05-31
EP0771567B1 (en) 2002-01-16
ES2170845T3 (es) 2002-08-16
SK281404B6 (sk) 2001-03-12
HU9602914D0 (en) 1996-12-30
US5932468A (en) 1999-08-03
UY24358A1 (es) 1996-11-13
ATE211928T1 (de) 2002-02-15
JP3024073B2 (ja) 2000-03-21
HUP9602914A2 (en) 1997-08-28
CZ292651B6 (cs) 2003-11-12
JPH09187273A (ja) 1997-07-22
ES2099678A1 (es) 1997-05-16
HUP9602914A3 (en) 2000-03-28

Similar Documents

Publication Publication Date Title
PT1220893E (pt) Meio para a cultura de celulas sem proteina e sem soro
NO993709D0 (no) Stabilisert blanding omfattende fibrinogen
PT850310E (pt) Molecula de dna circular com origem de replicacao condicional, metodo para a sua preparacao e utilizacao da mesma na terapia genica
DE69637147D1 (de) Transportproteine und deren verwendungen
EA199800159A1 (ru) Способ очистки вирусов с помощью хроматографии
DE59813677D1 (de) Verfahren zur Inaktivierung von lipidumhüllten Viren
DE69435307D1 (de) Bazillus Thuringiensis und dessen insektizide Proteine
DE59506355D1 (de) Chromatographische isolierung von nucleinsäuren
ATE265997T1 (de) Substituierte tetrahydronaphthalin- und dihydronaphthalin-derivate mit einer retinoiden und/oder retinoid antagonist-ähnlichen biologischen aktivität
AR004224A1 (es) Procedimiento para la inactivacion de virus en soluciones de proteinas
BR0014758A (pt) Sistemas e métodos para expressão de proteìna com alto rendimento
EA199901024A1 (ru) Фармацевтическая антивирусная композиция, содержащая глицирризиновую кислоту и, по меньшей мере, один белок, обладающий антивирусной активностью
EP0188262A3 (en) Process for the isolation of chicken egg white cystatine, antiviral agents containing it and its use as viral protease inhibitor
ES2056108T3 (es) Empleo de interacciones anticuerpo/antigeno para proteger o modular la actividad biologica.
ES2168282T3 (es) D-hidantoinasa recombinante, procedimiento para su preparacion y utilizacion.
BR9106762A (pt) Derivado de aldc e uso do mesmo
ATE161575T1 (de) Kulturmedien für drosophilazellen
DE69718911D1 (de) Interleukin - 8 als antivirale- und antitumorwirkstoffe
BR9607783A (pt) Linhagem de células e processo para a multiplicação de vírus de hidrofobia e sua detecção quantitativa
DE59611353D1 (de) Transketolase-verwandtes protein

Legal Events

Date Code Title Description
FG Grant, registration